A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction
Probity Medical Research · The University of Texas Health Science Center at Houston · +2 more institutions
Abstract
In previous studies, etanercept significantly improved plaque psoriasis and was well tolerated.
To examine further the efficacy and safety of etanercept and to assess maintenance of treatment effect after dose reduction of etanercept.
Citation impact
- FWCI
- 13.05
- Percentile
- 100%
- References
- 16
Authors
9- KPKim PappCorresponding
Probity Medical Research, The University of Texas Health Science Center at Houston
- SKStephen K. Tyring
The University of Texas Health Science Center at Houston, Hôpital Saint-Louis, Ludwig-Maximilians-Universität München, Probity Medical Research
- MLM. Lahfa
Ludwig-Maximilians-Universität München, Hôpital Saint-Louis, The University of Texas Health Science Center at Houston, Probity Medical Research
- JCJörg C. Prinz
Probity Medical Research, Hôpital Saint-Louis, Ludwig-Maximilians-Universität München, The University of Texas Health Science Center at Houston
- CGC.E.M. Griffiths
Ludwig-Maximilians-Universität München, Hôpital Saint-Louis, The University of Texas Health Science Center at Houston, Probity Medical Research
Topics & keywords
- SAINT
- Medicine
- Library science
- Family medicine
- Art history
- Art
- Good health and well-being